Literature DB >> 9549044

Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors.

M Li1, S Shioda, A Somogyvári-Vigh, H Onda, A Arimura.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is a new member of the secretin/VIP family of peptides. The specific receptor for PACAP has been cloned in rat, human, and bovine tissues. The distribution of the transcripts of PACAP receptor genes has been studied in various tissues using in situ hybridization. However, the unavailability of a specific antibody against the PACAP receptor has hampered further study of the expression of receptor proteins. In the present study, rabbit antisera were generated against a synthetic 25-residue peptide corresponding to the C-terminal intracellular domain of the rat PACAP receptor. To validate the specificity of the antisera, CHO cells and cells stably transfected with rat PACAP receptor cDNA were prepared. Using one of these antisera, the membrane and soluble fractions of the transformants were examined by Western blot analysis. Three bands were observed in subcellular fractions from the transfected CHO cells, but no bands were found in similar preparations from the nontransfected cells. A distinct 57-kDa band, which corresponds to the size of cloned rat PACAP receptor, was detected. In addition, a less intense band, larger than 57 kDa, and a very weakly stained band, smaller than 57 kDa, were demonstrated. All of these bands disappeared or were considerably diminished when the antiserum was preabsorbed with the synthetic immunogen peptide. This suggests that these bands are PACAP receptor-related proteins. The membranes from the transfected CHO cells bound to [125I]PACAP27. The size of the ligand/protein crosslinked product approximated 60 kDa, corresponding to the combined size of the PACAP receptor and PACAP27. No additional bands were observed, indicating that the immunopositive proteins larger or smaller than 57 kDa do not bind to the ligand and are not functional. Unlabeled PACAP27 and PACAP38, but not VIP, displaced the binding, suggesting that the receptors expressed in CHO cells are specific for PACAP. Solubilized membrane fractions prepared from rat brains were used for an immunoprecipitation study with [125I]PACAP27 and [125I]VIP. The PACAP receptor antiserum recognized [125I]PACAP-, but not [125I]VIP-bound proteins in the solubilized brain membrane fractions. Immunohistochemistry using this antiserum showed a distribution of PACAP receptor-like immunoreactivities similar to the distribution of the mRNA of PACAP receptor in the rat brain. Thus, the PACAP receptor antiserum is sufficiently specific to be used as a tool for studying the expression of PACAP receptors and related proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9549044     DOI: 10.1007/BF02778140

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  Immunohistochemical distribution and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda.

Authors:  L Yon; M Feuilloley; N Chartrel; A Arimura; J M Conlon; A Fournier; H Vaudry
Journal:  J Comp Neurol       Date:  1992-10-22       Impact factor: 3.215

2.  Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung.

Authors:  H C Lam; K Takahashi; M A Ghatei; S M Kanse; J M Polak; S R Bloom
Journal:  Eur J Biochem       Date:  1990-11-13

3.  Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.

Authors:  K Suda; D M Smith; M A Ghatei; J K Murphy; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  1991-05       Impact factor: 5.958

4.  Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes.

Authors:  A Arimura; A Somogyvári-Vigh; A Miyata; K Mizuno; D H Coy; C Kitada
Journal:  Endocrinology       Date:  1991-11       Impact factor: 4.736

5.  Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.

Authors:  J R Pisegna; S A Wank
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP).

Authors:  J A Morrow; E M Lutz; K M West; G Fink; A J Harmar
Journal:  FEBS Lett       Date:  1993-08-23       Impact factor: 4.124

7.  Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study.

Authors:  H Hashimoto; H Nogi; K Mori; H Ohishi; R Shigemoto; K Yamamoto; T Matsuda; N Mizuno; S Nagata; A Baba
Journal:  J Comp Neurol       Date:  1996-08-05       Impact factor: 3.215

8.  Pituitary adenylate cyclase-activating peptide in the adrenal gland of mammals: distribution, characterization and responses to drugs.

Authors:  A Tabarin; D Chen; R Håkanson; F Sundler
Journal:  Neuroendocrinology       Date:  1994-02       Impact factor: 4.914

9.  Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.

Authors:  P E Gottschall; I Tatsuno; A Miyata; A Arimura
Journal:  Endocrinology       Date:  1990-07       Impact factor: 4.736

10.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

Authors:  T Ishihara; R Shigemoto; K Mori; K Takahashi; S Nagata
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

View more
  5 in total

1.  Pituitary adenylate cyclase-activating polypeptide may function as a neuromodulator in guinea-pig adrenal medulla.

Authors:  M Inoue; N Fujishiro; K Ogawa; M Muroi; Y Sakamoto; I Imanaga; S Shioda
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

2.  Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development.

Authors:  D Vaudry; B J Gonzalez; M Basille; A Fournier; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 3.  Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis.

Authors:  Min Li; Akira Arimura
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

4.  Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.

Authors:  Min Li; Hisayuki Funahashi; Majambu Mbikay; Seiji Shioda; Akira Arimura
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

5.  Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.

Authors:  Masafumi Yokai; Takashi Kurihara; Atsuro Miyata
Journal:  Mol Pain       Date:  2016-05-12       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.